期刊
JOURNAL OF VIROLOGY
卷 96, 期 16, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/jvi.00588-22
关键词
full-length sequencing; HIV-HBV co-infection; human immunodeficiency virus; hepatitis B virus; HIV persistence
类别
资金
- Delaney AIDS Research Enterprise (DARE) - U.S. National Institutes of Health [1UM1AI126611-01, 1UM1AI164560-01]
- Australian National Health andMedical Research Council [APP1149990]
Co-infection with HBV and HIV increases mortality rates. Co-infected individuals have higher levels of genetically-intact HIV proviruses, which are associated with increased immune activation. ART decreases overall levels of HIV proviruses but increases the frequency of certain genetic defects within proviruses.
Co-infection with hepatitis B (HBV) and human immunodeficiency virus (HIV) increases overall and liver-related mortality. In order to identify interactions between these two viruses in vivo, full-length HIV proviruses were sequenced from a cohort of HIV-HBV coinfected participants and from a cohort of HIV mono-infected participants recruited from Bangkok, Thailand, both before the initiation of antiretroviral therapy (ART) and after at least 2 years of ART. The co-infected individuals were found to have higher levels of geneticallyintact HIV proviruses than did mono-infected individuals pre-therapy. In these co-infected individuals, higher levels of genetically-intact HIV proviruses or proviral genetic-diversity were also associated with higher levels of sCD14 and CXCL10, suggesting that immune activation is linked to more genetically-intact HIV proviruses. Three years of ART decreased the overall level of HIV proviruses, with fewer genetically-intact proviruses being identified in co-infected versus mono-infected individuals. However, ART increased the frequency of certain genetic defects within proviruses and the expansion of identical HIV sequences. IMPORTANCE With the increased availability and efficacy of ART, co-morbidities are now one of the leading causes of death in HIV-positive individuals. One of these co-morbidities is co-infection with HBV. However, co-infections are still relatively understudied, especially in countries where such co-infections are endemic. Furthermore, these countries have different subtypes of HIV circulating than the commonly studied HIV subtype B. We believe that our study serves this understudied niche and provides a novel approach to investigating the impact of HBV co-infection on HIV infection. We examine co-infection at the molecular level in order to investigate indirect associations between the two viruses through their interactions with the immune system. We demonstrate that increased immune inflammation and activation in HBV co-infected individuals is associated with higher HIV viremia and an increased number of genetically-intact HIV proviruses in peripheral blood cells. This leads us to hypothesize that inflammation could be a driver in the increased mortality rate of HIVHBV co-infected individuals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据